Bittencourt,Marcio Sommer. Estimating Cardiovascular Risk in HIV-Infected Patients. Arq. Bras. Cardiol. [online]. 2020, vol. 114, n. 1, [cited 2025-09-05], pp.76-77. Available from: <https://abccardiol.org/en/short-editorial/estimating-cardiovascular-risk-in-hiv-infected-patients/>. ISSN 0066-782X.
Figure 1
Dyslipidemia as a central element in atherosclerotic cardiovascular disease. ASCVD: atherosclerotic cardiovascular disease; LDL-C: low-density lipoprotein cholesterol. Limitations of statin-based therapy (non-exhaustive) include suboptimal LDL-C goal attainment, statin-associated adverse effects that may affect adherence, and potential drug interactions. Residual risk reflects the involvement of multiple underlying pathways.
